Back
Contineum Therapeutics, Inc. CTNM · Transcripts
website
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of s...51
Price10.3
Market Cap373.81 M
Float39.09 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents